Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytotoxic therapy and pregnancy

U Ebert1, H Löffler, W Kirch

  • 1Institute of Clinical Pharmacology, Medical School Technical University, Dresden, Germany.

Pharmacology & Therapeutics
|January 1, 1997
PubMed
Summary

Cytotoxic drug use in pregnancy, though risky for fetuses, is sometimes necessary for maternal survival. This review analyzes outcomes, finding that risk prediction for newborns is complex but possible.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the Emergence Mechanism of Carrot Sprites.

Geophysical research letters·2020
Same author

Determining Electric Fields in Thunderclouds With the Radiotelescope LOFAR.

Journal of geophysical research. Atmospheres : JGR·2020
Same author

Radio Emission Reveals Inner Meter-Scale Structure of Negative Lightning Leader Steps.

Physical review letters·2020
Same author

LOFAR Lightning Imaging: Mapping Lightning With Nanosecond Precision.

Journal of geophysical research. Atmospheres : JGR·2018
Same author

Influence of Carbimazole on Serum Levels and Haemodynamic Effects of Digoxin.

Clinical drug investigation·2016
Same author

Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.

Journal of neurology·2015

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Oncology

Background:

  • Cytotoxic agents are sometimes essential during pregnancy for life-saving maternal treatment.
  • Pregnancy exposure to these drugs poses significant risks to fetal development.

Purpose of the Study:

  • To analyze pregnancy outcomes following maternal exposure to cytotoxic agents.
  • To assess factors influencing fetal risk and predict newborn abnormality.
  • To review cases of cytotoxic drug use for various severe maternal conditions.

Main Methods:

  • A systematic review of 217 published cases (1983-1995) involving cytotoxic drug use during pregnancy.
  • Classification of cases based on the indication for cytotoxic therapy (leukemias, lymphomas, rheumatic diseases, neoplasms, other).
  • Analysis of drug type, dose, and gestational timing in relation to pregnancy outcomes.

Main Results:

  • Pregnancy outcomes varied, including teratogenicity, stillbirths, spontaneous abortions, and prematurity.
  • Factors like drug type, dose, and timing of exposure significantly impacted outcomes.
  • The study identified patterns linking specific exposures to adverse events.

Conclusions:

  • Maternal survival may necessitate cytotoxic therapy despite fetal risks.
  • Predicting individual newborn abnormality risk requires careful consideration of multiple exposure factors.
  • Further research is needed to refine risk assessment and management strategies for pregnant patients requiring cytotoxic treatment.

Related Experiment Videos